Network origin in Claus Crone Fuglsang first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Microbiogen Pty Ltd.
 Microbiogen Pty Ltd. BiotechnologyHealth Technology Microbiogen Pty Ltd. develops non-genetically modified yeast. It develop non-genetically modified yeast to generate yeast strains for industrial purposes, which are used for ethanol production, high quality animal feed, baking, yeast extracts, enzymes, antioxidants, and waste stream management amongst others. The company is headquartered in Lane Cove, Australia.
8
| Private Company | Biotechnology | 8 |
| Public Company | Medical Specialties | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Claus Crone Fuglsang via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Moelis & Co. LLC
 Moelis & Co. LLC Investment Banks/BrokersFinance Founded in 2007, Moelis & Co. LLC is a registered broker/dealer headquartered in New York City. The firm is a subsidiary of Moelis & Company (NYSE: MC), a global investment bank that provides financial advisory, capital raising and asset management services to corporations, institutions and governments. Moelis & Co. LLC provides an array of trading and execution services for their clients. They do not provide any internal research. | Investment Banks/Brokers | Corporate Officer/Principal | |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Public Communications Contact | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member | |
| RECORDATI | Pharmaceuticals: Major | Director/Board Member | |
| SARTORIUS AG | Pharmaceuticals: Major | Director of Finance/CFO | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Chief Executive Officer | |
Northwick Park Institute For Medical Research
 Northwick Park Institute For Medical Research Miscellaneous Commercial ServicesCommercial Services Northwick Park Institute For Medical Research is a charity-based independent medical research institute. The private company is based in Middlesex, UK. The British company was founded in 1994. | Miscellaneous Commercial Services | Director/Board Member | |
| School of Oriental & African Studies | College/University | Director/Board Member | |
Chr. Hansen A/S
 Chr. Hansen A/S Pharmaceuticals: OtherHealth Technology Chr. Hansen A/S engages in bioscience research that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. It also develops and produces cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed. The company was founded by Christian D. A Hansen in 1874 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
| University of London | College/University | Doctorate Degree | |
| Universität zu Köln | College/University | Undergraduate Degree | |
| The University of New South Wales | College/University | Doctorate Degree Undergraduate Degree | |
| Macquarie University | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Aarhus | College/University | Graduate Degree Graduate Degree | |
| The University of Sydney | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Technical University of Denmark | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
| University of Copenhagen | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Essen Instruments, Inc.
 Essen Instruments, Inc. Electronic Equipment/InstrumentsElectronic Technology Essen Instruments, Inc. engages in the development and manufacture of cell and bead based screening solutions. It offers phenotypic drug discovery, antibody discovery and in vitro toxicity testing. The firm’s proprietary technologies, instrumentation, assays and software products address the pervasive need to provide turnkey solutions that increase productivity in pharmaceutical, biotechnology and life science research. The company’s products are used in biologics discovery, small molecules, in vitro tox and cellular research antibody applications. The company was founded by R. Terry Dunlay, Larry A. Sklar, and Bruce S. Edwards in 2006 and is headquartered in Ann Arbor, MI. | Electronic Equipment/Instruments | Director/Board Member | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Glaxosmithkline Investments Pty Ltd.
 Glaxosmithkline Investments Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Investments Pty Ltd. is an Australian company. | Pharmaceuticals: Major | Sales & Marketing | |
Sartorius North America, Inc.
 Sartorius North America, Inc. Medical SpecialtiesHealth Technology Part of Sartorius AG, Sartorius North America, Inc. is a private company based in Brentwood, NY. | Medical Specialties | Director/Board Member | |
Sartorius Stedim North America, Inc.
 Sartorius Stedim North America, Inc. Wholesale DistributorsDistribution Services Part of Sartorius AG, Sartorius Stedim North America, Inc. is a private company that provides technologies, platforms, and partnerships to ensure that new scientific discoveries can be translated more quickly into effective patient care. The company is based in Bohemia, NY. Sartorius is part of the solution to ensure better health for more people. The company offers a wide range of products and services, including bioreactors, cell culture media and buffers, cell culture reagents and supplements, live cell imaging and analysis, pipetting and dispensing, and process analytical technology and data analytics. Sartorius has acquired several companies, including Albumedix, Novasep Chromatography Division, ALS Automated Lab Solutions, Xell, CellGenix, and WaterSep Bioseparations, to expand its portfolio and provide innovative and complementary technologies. | Wholesale Distributors | Director/Board Member | |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer | |
Sartorius Corporate Administration GmbH
 Sartorius Corporate Administration GmbH Miscellaneous Commercial ServicesCommercial Services Part of Sartorius AG, Sartorius Corporate Administration GmbH provides management and administration services. The private company is based in Goettingen, Germany. The CEO of the German company is Rainer Lehmann. | Miscellaneous Commercial Services | Chief Executive Officer | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chief Executive Officer | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Bioporto Diagnostics A/S
 Bioporto Diagnostics A/S BiotechnologyHealth Technology Part of Bioporto A/S, Bioporto Diagnostics A/S is a Danish company that engages in research and experimental development on biotechnology. The private company is based in Gentofte, Denmark. Peter Morch Eriksen has been the CEO of the company since 2013. | Biotechnology | President Chief Executive Officer | |
Sartorius Stedim Filters, Inc.
 Sartorius Stedim Filters, Inc. Industrial MachineryProducer Manufacturing Part of Sartorius AG, Sartorius Stedim Filters, Inc. is a Puerto Rican company that manufactures liquid filters. The private company is based in Yauco, Puerto Rico. | Industrial Machinery | Director/Board Member | |
Moelis & Co. (UK) LLP
 Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The private company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010. | Investment Banks/Brokers | Corporate Officer/Principal | |
Sartorius Corp.
 Sartorius Corp. Medical SpecialtiesHealth Technology Part of Sartorius AG, Sartorius Corp. is a private company that manufactures laboratory equipment and surgical instruments. The company is based in Bohemia, NY. | Medical Specialties | Director/Board Member | |
| Sartorius (Shanghai) Trading Co., Ltd. | Director/Board Member | ||
| CONVATEC GROUP PLC | Medical Specialties | Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chief Executive Officer | |
UTILITY therapeutics Ltd.
 UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | Pharmaceuticals: Generic | Founder | |
| CENTOGENE N.V. | Miscellaneous Commercial Services | Chief Executive Officer | |
Clinical-Microbiomics A/S
 Clinical-Microbiomics A/S BiotechnologyHealth Technology Clinical-Microbiomics A/S is a Danish private company located in Copenhagen with domestic subsidiaries. The firm engages in conducting biotechnology research and experimental development. Anders Grøn is currently the CEO of the company. | Biotechnology | Chairman | |
PKC SEGU Systemelektrik GmbH
 PKC SEGU Systemelektrik GmbH Electrical ProductsProducer Manufacturing PKC SEGU Systemelektrik GmbH engages in the production of wiring harnesses as well as electronic and plastic components for the automotive and commercial vehicle industries. These include anti-lock braking system and assembled cables. The company was founded on January 29,1993 and is headquartered in Barchfeld-Immelborn, Germany. | Electrical Products | Founder | |
Shire International GmbH
 Shire International GmbH Medical DistributorsDistribution Services Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a Swiss company that wholesales pharmaceutical products. | Medical Distributors | Corporate Officer/Principal | |
| Sartorius Stedim (Shanghai) Trading Co., Ltd. | Director/Board Member |
Statistics
International
| Denmark | 14 |
| United Kingdom | 11 |
| United States | 9 |
| Germany | 7 |
| Switzerland | 5 |
Sectoral
| Health Technology | 20 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 5 |
| Distribution Services | 3 |
Operational
| Director/Board Member | 146 |
| Chairman | 50 |
| Independent Dir/Board Member | 28 |
| Chief Executive Officer | 27 |
| Corporate Officer/Principal | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Peter Morch Eriksen | 32 |
| Jesper Brandgaard | 25 |
| Lise Kaae Lövbjerg | 25 |
| Heine Dalsgaard | 22 |
| Andrew Fay | 21 |
| Kasim Kutay | 21 |
| Cees de Jong | 18 |
| Paul Anthony Mieyal | 18 |
| Kim Stratton | 14 |
| Morten Otto Sommer | 13 |
| Rainer Lehmann | 13 |
| Winnie Hojvang Bügel | 9 |
| Mario Maia | 7 |
| Ester Baiget | 6 |
| Thea Wulff Olesen | 6 |
- Stock Market
- Insiders
- Claus Crone Fuglsang
- Company connections
